Risk of thrombosis and mortality in inflammatory bowel disease

por Andrade, Adriana R., Barros, Luísa L., Azevedo, Matheus F. C., Carlos, Alexandre S., Damião, Aderson O. M. C., Sipahi, Aytan M., Leite, André Z. A.
Publicado 2018

Safety and efficacy of tofacitinib for treatment of ulcerative colitis: final analysis of OCTAVE Open, an open‐label, long‐term extension study with up to 7.0 years of treatment...

por Sandborn, William J., Lawendy, Nervin, Danese, Silvio, Su, Chinyu, Loftus, Edward V., Hart, Ailsa, Dotan, Iris, Damião, Adérson O. M. C., Judd, Donna T., Guo, Xiang, Modesto, Irene, Wang, Wenjin, Panés, Julian
Publicado 2021

Temporal trends in the epidemiology of inflammatory bowel diseases in the public healthcare system in Brazil: A large population-based study

por Quaresma, Abel B., Damiao, Aderson O.M.C., Coy, Claudio S.R., Magro, Daniela O., Hino, Adriano A.F., Valverde, Douglas A., Panaccione, Remo, Coward, Stephanie B., Ng, Siew C., Kaplan, Gilaad G., Kotze, Paulo G.
Publicado 2022

Prevalence of celiac disease among blood donors in SÃO PAULO – the most populated city in Brazil

por Alencar, Marília Lage, Ortiz-Agostinho, Carmen Lucia, Nishitokukado, Iêda, Damião, Adérson O.M.C., Abrantes-Lemos, Clarice P., de Arruda Leite, André Zonetti, de Brito, Thales, de Alencar Fischer Chamone, Dalton, da Silva, Maria Elizabeth Rossi, Giannella-Neto, Daniel, Sipahi, Aytan Miranda
Publicado 2012